As a dietitian who has been open about my lifelong weight struggles, Id already felt the sting of stigma
& Tikkanen, C
Although previous studies showed a lack of therapeutic benefit for GIP agonists, current studies show that the glucose lowering and weight loss effects of tirzepatide are at least as effective as GLP-1 RAs with a similar adverse effect profile
GLP-1 agonist benefits are multiple regarding blood glucose control in the form of reducing Hemoglobin A1c (HBA1c) by 1.1%-1.6%, reducing postprandial excursions, and decreasing weight
The FDA said it will give compounding pharmacies time to wind down "to avoid unnecessary disruption to patient treatment." The FDA said compounders have until April or May, depending on their regulatory status, to stop compounding, distributing or dispensing semaglutide injection products
Compounded semaglutide: Contains the same active ingredient as both Ozempic and Wegovy, bypassing some of the brand-name coverage issues